Drugs / EVT801
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05114668 | Nov 2021 → Nov 2024 | cancer | Kazia Therapeutics Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EVT801 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05114668 ↗ |
| Route | Oral | “dosed orally” NCT05114668 ↗ |